Literature DB >> 10924568

Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging-a meta-analysis and Bayesian analysis.

K A Frei1, K Kinkel, H M Bonél, Y Lu, C Zaloudek, H Hricak.   

Abstract

PURPOSE: To determine if, in a patient with an endometrial cancer, in addition to the knowledge of tumor grade, preoperative magnetic resonance (MR) imaging findings contribute to treatment stratification and specialist referral.
MATERIALS AND METHODS: By using a MEDLINE literature search and institutional pathology reports, pretest probabilities for myometrial invasion were correlated with tumor grade. Likelihood ratios (LRs) were obtained through summary receiver operating characteristics.
RESULTS: The mean pretest probabilities of deep myometrial invasion were derived from seven articles (1,875 patients) and from 125 institutional pathology reports. LRs for the prediction of myometrial invasion with contrast-enhanced MR imaging were derived from nine studies (742 patients); positive and negative LRs were 10.11 and 0.1, respectively. The mean weighted pretest probabilities of deep myometrial invasion in patients with tumor grades 1, 2, or 3 were 13%, 35%, or 54%, respectively. Posttest probabilities of deep myometrial invasion for grades 1, 2, or 3 increased to 60%, 84%, or 92%, respectively, for positive and decreased to 1%, 5%, or 10%, respectively, for negative MR imaging findings.
CONCLUSION: Use of contrast-enhanced MR imaging significantly affects the posttest probability of deep myometrial invasion in patients with all grades of endometrial cancer and could be used to select patients for specialist referral.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10924568     DOI: 10.1148/radiology.216.2.r00au17444

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  27 in total

1.  Advances in magnetic resonance imaging of endometrial cancer.

Authors:  Evis Sala; Andrea Rockall; Rahel A Kubik-Huch
Journal:  Eur Radiol       Date:  2010-11-27       Impact factor: 5.315

2.  Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging.

Authors:  K Kinkel; R Forstner; F M Danza; L Oleaga; T M Cunha; A Bergman; J O Barentsz; C Balleyguier; B Brkljacic; J A Spencer
Journal:  Eur Radiol       Date:  2009-02-05       Impact factor: 5.315

3.  A thickened or indistinct junctional zone on T2-weighted MR images in patients with endometrial carcinoma: pathologic consideration based on microcirculation.

Authors:  Yumiko Oishi Tanaka; Masato Nishida; Hajime Tsunoda; Yoshihito Ichikawa; Yukihisa Saida; Yuji Itai
Journal:  Eur Radiol       Date:  2003-01-25       Impact factor: 5.315

Review 4.  Predictive value of T2-weighted imaging and contrast-enhanced MR imaging in assessing myometrial invasion in endometrial cancer: a pooled analysis of prospective studies.

Authors:  Lian-Ming Wu; Jian-Rong Xu; Hai-Yan Gu; Jia Hua; E Mark Haacke; Jiani Hu
Journal:  Eur Radiol       Date:  2012-08-04       Impact factor: 5.315

5.  Endometrial Cancer: Combined MR Volumetry and Diffusion-weighted Imaging for Assessment of Myometrial and Lymphovascular Invasion and Tumor Grade.

Authors:  Stephanie Nougaret; Caroline Reinhold; Shaza S Alsharif; Helen Addley; Jocelyne Arceneau; Nicolas Molinari; Boris Guiu; Evis Sala
Journal:  Radiology       Date:  2015-04-30       Impact factor: 11.105

6.  Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer.

Authors:  Nadim Bou Zgheib; Douglas C Marchion; Stephen H Bush; Patricia L Judson; Robert M Wenham; Sachin M Apte; Johnathan M Lancaster; Jesus Gonzalez-Bosquet
Journal:  Oncol Lett       Date:  2015-11-06       Impact factor: 2.967

7.  Prediction of staging with preoperative parameters and frozen/section in patients with a preoperative diagnosis of grade 1 endometrioid tumor in endometrial cancer.

Authors:  Alper Karalok; Işın Ureyen; Yıldız Reis; Ozge Oktay; Taner Turan; Nurettin Boran; Dilek Bülbül; Gökhan Tulunay; Mehmet Faruk Köse
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-01-30

8.  [Endometrial carcinoma].

Authors:  K Engelhard
Journal:  Radiologe       Date:  2011-07       Impact factor: 0.635

9.  Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?

Authors:  Marcos Ballester; Martin Koskas; Charles Coutant; Elisabeth Chéreau; Jeremy Seror; Roman Rouzier; Emile Daraï
Journal:  BMC Cancer       Date:  2010-08-30       Impact factor: 4.430

Review 10.  PET/CT and cross sectional imaging of gynecologic malignancy.

Authors:  Revathy B Iyer; Aparna Balachandran; Catherine E Devine
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.